#NationalPharmacovigilanceWeek2022
Theme: Encouraging Reporting ADR by Consumer
Pharmacovigilance in real Life.ppt
Presented on 16/09/2022 at Bengal School of Technology, Chunchura, Hooghly
History and Progress of Pharmacovigilance, Significance of Safety Monitoring, Pharmacovigilance in India And International Aspects, WHO International Drug Monitoring Programme, WHO and Regulatory Terminologies of ADR, Evaluation of Medication Safety, Establishing Pharmacovigilance Centres in Hospitals, Industry and National Programmes Related to Pharmacovigilance, Roles and Responsibilities in Pharmacovigilance, International Non-Proprietary Names for Drugs, International Classification of Diseases, Passive and Active Surveillance, Comparative Observational Studies, Targeted Clinical Investigations and Vaccine Safety Surveillance, Aris G Pharmacovigilance, VigiFlow, Statistical Methods for Evaluating Medication Safety Data
History and Progress of Pharmacovigilance, Significance of Safety Monitoring, Pharmacovigilance in India And International Aspects, WHO International Drug Monitoring Programme, WHO and Regulatory Terminologies of ADR, Evaluation of Medication Safety, Establishing Pharmacovigilance Centres in Hospitals, Industry and National Programmes Related to Pharmacovigilance, Roles and Responsibilities in Pharmacovigilance, International Non-Proprietary Names for Drugs, International Classification of Diseases, Passive and Active Surveillance, Comparative Observational Studies, Targeted Clinical Investigations and Vaccine Safety Surveillance, Aris G Pharmacovigilance, VigiFlow, Statistical Methods for Evaluating Medication Safety Data
Establishment of Pharmacovigilance ProgrammeNipun Gupta
1. Pharmacovigilance
2. Pathway of PvPI
3. Establishment of PV Programme
in Hospital
4. Establishment of PV Programme
in Industry
5. Contract Research Organization
6. Establishment a National Programme
International classification of disease and International non-proprietary nam...JAYANTHBM
This slideshare give you a knowledge about international classification of diseases and international non-proprietary names of drugs. And also about the guidelines how they classify the disease and where we can find this type of classification and what is its primary use and who use this type of classification and use of non-proprietary names.
Anatomic Therapeutic Chemical Classification, Defined daily dose, Drug utilis...Dr.Amreen Saba Attariya
detailed information about Anatomic Therapeutic Chemical Classification, Defined daily dose, Drug utilisation, DU90%, WHO Collaborting Centre for drug statistic methodology, DDD/1000inhabitants/day, DDD/100beddays, DDD/1000inhabitants/year, Pediatric DDD, ATC & DDD in drug utilisation research, Electronic Prescribing, Guidelines for ATC classification & DDD assignment 2016
An Individual Case Safety Report (ICSR) is a document that contains information about a single adverse event or suspected adverse reaction to a medicinal product. It is a critical component of pharmacovigilance, which is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems.
ICSRs are typically generated by healthcare professionals, patients, or clinical trial investigators, and they include a detailed description of the adverse event, patient demographics, medical history, and details about the medicinal product(s) involved. The report also contains an assessment of the causal relationship between the adverse event and the medicinal product(s), as well as any medical interventions or outcomes that occurred.
ICSRs are essential for identifying potential safety issues with medicinal products and for assessing the risk-benefit profile of a product. They also help to ensure that regulatory authorities, such as the FDA or EMA, are notified of any safety concerns associated with a medicinal product.
ICSRs must comply with international reporting requirements, which specify the information that must be included in the report, as well as the timeframe for submission. The information in an ICSR must be accurate and complete to enable effective analysis and evaluation of the safety data.
ICSRs are a crucial aspect of pharmacovigilance and the regulatory process, as they provide valuable information for the ongoing evaluation of the safety of medicinal products. The prompt reporting of ICSRs is essential for ensuring the timely detection and assessment of any safety concerns associated with the use of medicinal products.
Establishment of Pharmacovigilance ProgrammeNipun Gupta
1. Pharmacovigilance
2. Pathway of PvPI
3. Establishment of PV Programme
in Hospital
4. Establishment of PV Programme
in Industry
5. Contract Research Organization
6. Establishment a National Programme
International classification of disease and International non-proprietary nam...JAYANTHBM
This slideshare give you a knowledge about international classification of diseases and international non-proprietary names of drugs. And also about the guidelines how they classify the disease and where we can find this type of classification and what is its primary use and who use this type of classification and use of non-proprietary names.
Anatomic Therapeutic Chemical Classification, Defined daily dose, Drug utilis...Dr.Amreen Saba Attariya
detailed information about Anatomic Therapeutic Chemical Classification, Defined daily dose, Drug utilisation, DU90%, WHO Collaborting Centre for drug statistic methodology, DDD/1000inhabitants/day, DDD/100beddays, DDD/1000inhabitants/year, Pediatric DDD, ATC & DDD in drug utilisation research, Electronic Prescribing, Guidelines for ATC classification & DDD assignment 2016
An Individual Case Safety Report (ICSR) is a document that contains information about a single adverse event or suspected adverse reaction to a medicinal product. It is a critical component of pharmacovigilance, which is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems.
ICSRs are typically generated by healthcare professionals, patients, or clinical trial investigators, and they include a detailed description of the adverse event, patient demographics, medical history, and details about the medicinal product(s) involved. The report also contains an assessment of the causal relationship between the adverse event and the medicinal product(s), as well as any medical interventions or outcomes that occurred.
ICSRs are essential for identifying potential safety issues with medicinal products and for assessing the risk-benefit profile of a product. They also help to ensure that regulatory authorities, such as the FDA or EMA, are notified of any safety concerns associated with a medicinal product.
ICSRs must comply with international reporting requirements, which specify the information that must be included in the report, as well as the timeframe for submission. The information in an ICSR must be accurate and complete to enable effective analysis and evaluation of the safety data.
ICSRs are a crucial aspect of pharmacovigilance and the regulatory process, as they provide valuable information for the ongoing evaluation of the safety of medicinal products. The prompt reporting of ICSRs is essential for ensuring the timely detection and assessment of any safety concerns associated with the use of medicinal products.
Slides includes ADR monitoring process, Safety reporting, what is pharmacovigilance, types of ADR, basic terms in ADR monitoring, what is PvPI in India, role. stakeholders, ADR reporting form, Apps, Role of community Pharmacist in ADR monitoring, Importance of ADR monitoring, etc.
Pharmacovigilance at NRSMC for last 2yrs and serial look since dec, 2014 ju...Anindya Banerjee
Comparison of ADR monitoring data over 2 consecutive years
&
A study of ADR monitoring data over 4.7 years in a tertiary care teaching hospital of East India
Pharmacovigilance Activity at NRS Medical College in 2017 and 3 Years of Comp...Anindya Banerjee
Pharmacovigilance Activity at NRS Medical College in 2017 AND 3 Years of Comparative Study under NCC-PvPI, IPC by Patient Safety-Pharmacovigilance Associate Mr. Anindya Banerjee
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Pharmacovigilance in real Life.ppt
1. Nilratan Sircar Medical College
Kolkata
National Pharmacovigilance Week
17th – 23rd September, 2022
Theme: Encouraging Reporting of ADR by Consumers
Under aegis of National Coordination Centre-Pharmacovigilance
Programme of India, Indian Pharmacopoeia Commission, Ministry
of Health & Family Welfare, Govt. of India
2. Pharmacovigilance in Real Life
Anindya Banerjee
Sr. Pharmacovigilance Associate
Dept of Pharmacology
NRS Medical College, Kolkata
And
National Coordination Centre – Pharmacovigilance Program of India
Indian Pharmacopoeia Commission, Ghaziabad
Ministry of Health & Family Welfare
Govt of India
3.
4.
5. Pharmacovigilance
Pharmacovigilance: It is a science and activity related
to
Detection
Assessment
Understanding
&
Prevention
of adverse drug reactions or any other drug related
problems
WHO 2002
6. Minimum Role of a Community and Hospital
Pharmacist to prevent Adverse reaction
Monitoring of Drug Utilization
Health Promotion
Alert Stakeholders
(Prescriber, Nurse and
Patient) regarding use of
Polypharmacy and Drug-
Drug Interaction, Drug-
Food Interaction
Full Filling the activity of Detection, i.e,
the first step of Pharmacovigilance
7. Contd..
If you, the Pharmacist or Clinical Pharmacist knows the
Pharmacology of Medicine, then you can possibly assess the
upcoming ADVERSE DRUG REACTION, which is going to be
happen
Refer Primary, Secondary or Tertiary sources of Drug
Information from DIC, thus you can Understand
ADR
Occurred
ADR going to be
Occurred
YES Not YET
Prevent ADVERSE REACTION
ADR
Occurred
ADR going to be
Occur
Before the Occurrence
of ADR
After Occurrence of
ADR by Treatment
8. A Glimpse of an ADVERSE DRUG
REACTION
* 23yr old female patient got Wykoryl induced
Toxic Epidermal Necrolysis (TEN), No other
medication history for last 2 months, no early
history of drug rxn.
* Therapy period: 4 days
* Indication: Common Cough & Cold
* ADR Period: 7 Days.
•SERIOUS ADVERSE REACTION???:
- YES, Admitted to Hospital due to the incident
(Reason 1)
During Hospital stay her eyes were
permanently damaged (Reason 2).
On 7th Day Patient Died (Reason 3).
Disclaimer : The Snapshot has been taken with permission of Patient party and Medical
Super of NRSMCH
9. As a Consumer – Whom and/or Where to
report?
• Red colored Suspected Adverse Drug Reaction
Reporting Form is available at the website of
NCC-PvPI, IPC – Download and fill up, and send
the filled in Form at pvpi.ipcindia@gmail.com
or
• You may dial the mobile number: 8670117829
or
• Drop Email: anindyabanerjee1988@gmail.com
or
• Contact at: Pharmacovigilance Centre, Dept of
Pharmacology, 4th Floor, Academy Building, NRS
Medical College, 138, AJC Bose Road, Kolkata –
14
or
• PvPI Toll Free Number: 1800-180-3024
Or
• Through Mobile (ADR-PvPI App) from
downloadable via Google Play Store
Or
• Blue Coloured Consumer Reporting Form is
downloadable from the website of NCC-PvPI, IPC
and send report to NCC-PvPI through mail :
pvpi.ipcindia@gmail.com
10. Process of reporting Adverse Drug Reaction at
NRSMCH and/or National Coordination Centre - In
Nutshell
11. Acknowledgement
• Dr. Ananya Mandal, Associate Professor, Dept of
Pharmacology and AMC Coordinator under National
Coordination Centre - Pharmacovigilance Programme of India
(NCC-PvPI), Indian Pharmacopoeia Commission (IPC)
• Dr. Suman Chattopadhyay, Assistant Professor Dept of
Pharmacology and CAC Member under NCC-PvPI, IPC
• Prof & Head, Dept of Pharmacology, Nilratan Sircar Medical
College, Kolkata
• Dr. Jai Prakash, Sr. Principal Scientific Officer, NCC-PvPI,
IPC
13. TAKE HOME MESSAGE:
To keep AWAKE or ALERT, to KEEP WATCH
Anindya Banerjee
Sr. Pharmacovigilance Associate
Dept of Pharmacology
NRS Medical College, Kolkata
And
National Coordination Centre – Pharmacovigilance Program of India
Indian Pharmacopoeia Commission, Ghaziabad
Ministry of Health & Family Welfare
Govt of India